Clinical trials of combining the data from the Japan Society for Hematopoietic cell transplantation (JSHCT) and the Japan Adult Leukemia Study Group (JALSG)-Reference-Cited by-同舟云学术

Clinical trials of combining the data from the Japan Society for Hematopoietic cell transplantation (JSHCT) and the Japan Adult Leukemia Study Group (JALSG)

Published:2017 Issue:1 Volume:6 Page:8-14
ISSN:2186-5612
Container-title:Journal of Hematopoietic Cell Transplantation
language:en
Short-container-title:Journal of Hematopoietic Cell Transplantation

Author:

Kako Shinichi¹

Affiliation:

1. Division of Hematology, Saitama Medical Center, Jichi Medical University

Publisher

The Japan Society for Hematopoietic Stem Cell Transplantation

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/hct/6/1/6_8/_pdf

Reference16 articles.

1. 1. Kako S, Morita S, Sakamaki H, et al. A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor. Leukemia. 2011; 25: 259-265.

2. 2. Atsuta Y, Suzuki R, Yoshimi A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007; 86: 269-274.

3. 3. Kako S. A decision analysis of validity of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor for adult acute lymphoblastic leukemia in first remission. Rinsho Ketsueki. 2010; 51: 464-470.

4. 4. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985; 5: 157-177.

5. 5. Cutler CS, Lee SJ, Greenberg P, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 2004; 104: 579-585.